All Stories

  1. Seasonal Variations in the Risk of Outpatient Acute Kidney Injury in Patients with Chronic Kidney Disease
  2. A Case of Acquired LCAT Deficiency with the Discrepancy between Spontaneous Resolution of Proteinuria and Continually Low HDL Cholesterol Levels
  3. Trajectories of kidney function over 10 years in patients with chronic kidney disease: a 10 year follow-up of FROM-J study
  4. Central Serous Chorioretinopathy in Parallel With Onset and Relapses of Minimal Change Nephrotic Syndrome: A 28-Year Case Follow-Up
  5. A case of tubulointerstitial nephritis with infiltration of neutrophils and interleukin-17-positive cells associated with Behçet’s disease
  6. Renin-angiotensin system inhibitor use and cardio-renal outcomes in non-proteinuric chronic kidney disease: a post-hoc analysis of the Frontier of Renal Outcome Modification-Japan study
  7. Dental infection is associated with early relapse in patients with ANCA-associated vasculitis
  8. Severe Hypercholesterolemia Caused by Mesalazine Which Is a Key Drug of Ulcerative Colitis: A Case Report
  9. Correction: Continuous glucose monitoring reveals periodontitis-induced glucose variability, insulin resistance, and gut microbiota dysbiosis in mice
  10. Elucidation of puberulic acid–induced nephrotoxicity using stem cell-based kidney organoids
  11. Kidney Organoids: Current Advances and Applications
  12. A Multicenter, Prospective, Observational, and Single-Arm Interventional Study of Mirogabalin in Diabetic Peripheral Neuropathic Pain: Rationale and Design of Dia-NeP
  13. Efficacy and safety of esaxerenone with and without sodium–glucose cotransporter-2 inhibitor use in hypertensive patients with type 2 diabetes mellitus: a pooled analysis of five clinical studies
  14. A pilot transcriptomic study of a novel multitargeted BRT regimen for anti–MDA5 antibody-positive dermatomyositis: improving survival over conventional therapy
  15. Inhibitory Effects of Vandetanib on Catecholamine Synthesis in Rat Pheochromocytoma PC12 Cells
  16. Dyspnea with Hemidiaphragm Elevation in a Patient with Giant Cell Arteritis
  17. Efficacy and safety of esaxerenone in hypertensive patients with chronic kidney disease, with or without type 2 diabetes mellitus: a pooled analysis of five clinical studies
  18. Missing the Target: A Scoping Review of the Use of Percent Weight Loss for Obesity Management
  19. Association of anti-citrullinated protein antibodies with changes in bone density in patients with rheumatoid arthritis treated with romosozumab for one year: A cohort study
  20. Dotinurad Treatment for Patients With Hyperuricemia Complicating CKD
  21. Role of galectin-9 in the development of gestational diabetes mellitus
  22. Nephronophthisis and Retinitis Pigmentosa (Senior-Loken Syndrome) After Living-Donor Kidney Transplantation: Twelve-Year Follow-Up in a Young Woman
  23. A Case of IgA Nephropathy With Membranoproliferative Glomerulonephritis‐Like Features
  24. Text mining for case report articles on “peritoneal dialysis” from PubMed database
  25. Serum uric acid level is associated with renal arteriolar hyalinosis and predicts post-donation renal function in living kidney donors
  26. Vesicular Glutamate Transporter 3 Is Involved in Glutamatergic Signalling in Podocytes
  27. PARylation-mediated post-transcriptional modifications in cancer immunity and immunotherapy
  28. The association of fasting triglyceride variability with renal dysfunction and proteinuria in medical checkup participants
  29. Supplement-Induced Acute Kidney Injury Reproduced in Kidney Organoids
  30. Vesicular Glutamate Transporter 3 Is Involved in Glutamatergic Signaling in Podocytes
  31. Hypoglycemia and hyperinsulinemia induced by phenolic uremic toxins in CKD and DKD patients
  32. The Gut–Kidney Axis in Chronic Kidney Diseases
  33. HOMA-beta independently predicts survival in patients with advanced cancer on treatment with immune checkpoint inhibitors
  34. Successful Treatment for Life Threatening Recurrent Non-traumatic Rectus Sheath Hematoma in a Case with Microscopic Polyangiitis with Rapidly Progressive Glomerulonephritis
  35. Pericardial artery lymphoma in a patient with dermatomyositis: A case report
  36. The Gut-Kidney Axis in Chronic Kidney Diseases
  37. A Case of Pseudoxanthoma Elasticum with Juvenile-onset Hypertension
  38. Association between discontinuity of care and patient trust in the usual rheumatologist among patients with systemic lupus erythematosus: a cross-sectional study
  39. The Change in Public Perception and Knowledge Acquisition Methods of Chronic Kidney Disease Among General Population in Okayama Prefecture, Japan
  40. Characteristics of diabetes mellitus patients with nonviral chronic liver disease who developed hepatocellular carcinoma
  41. Noncoding RNAs and diabetic kidney disease
  42. Histological differences related to autophagy in the minor salivary gland between primary and secondary types of Sjögren’s syndrome
  43. A case of renal hypouricemia due to T217M mutation in SLC22A12 incidentally associated with IgA nephropathy
  44. Factors influencing the efficacy and safety of esaxerenone in hypertensive patients: a pooled analysis of five clinical studies on different comorbidities
  45. Guidelines for clinical evaluation of chronic kidney disease in early stages
  46. A case of membranous nephropathy complicated by Cronkhite–Canada syndrome successfully treated with mizoribine
  47. Late-onset renal variant Fabry disease with R112H mutation and mild increase in plasma globotriaosylsphingosine: a case report
  48. Preventive effects of vasohibin-2-targeting peptide vaccine for diabetic nephropathy
  49. All Three in One: A Cohort, Proteomics, and Mendelian Randomization Biomarker Study
  50. Evaluating the associations between compliance with CKD guideline component metrics and renal outcomes
  51. Factors affecting the sodium‐glucose cotransporter 2 inhibitors‐related initial decline in glomerular filtration rate and its possible effect on kidney outcome in chronic kidney disease with type 2 diabetes: The Japan Chronic Kidney Disease Database
  52. A multicenter, open‐label, single‐arm trial of the long‐term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE‐02)
  53. Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3)
  54. Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA–KIDNEY
  55. Effects of HIF-PHD inhibitors in kidney development
  56. Association of serum magnesium levels with renal prognosis in patients with chronic kidney disease
  57. NDUFS4 regulates cristae remodeling in diabetic kidney disease
  58. Immunosuppressive Treatment for an anti-U<sub>1</sub> Ribonucleoprotein Antibody-positive Patient with Pulmonary Arterial Hypertension
  59. Relapse of Ulcerative Colitis with Immune Thrombocytopenia and Pyoderma Gangrenosum Subsequent to Receiving COVID-19 Vaccination
  60. Renal outcomes with sodium‐glucose cotransporter 2 inhibitors in Japanese people with grade 3 chronic kidney disease and type 2 diabetes: Analysis of medical administrative databases
  61. GRP78 Contributes to the Beneficial Effects of SGLT2 Inhibitor on Proximal Tubular Cells in DKD
  62. The first presentation of a case of nail-patella syndrome newly diagnosed at the onset of rheumatoid arthritis: a case report
  63. A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01)
  64. Inhibition of Amino Acids Influx into Proximal Tubular Cells Improves Lysosome Function in Diabetes
  65. Kidney Veno-Muscular Characteristics and Kidney Disease Progression: A Native Kidney-Biopsy Study
  66. Preventive effect of culture supernatant of epithelial-like peritoneal mesothelial cells on peritoneal fibrosis
  67. Neutrophil Elastase Inhibition by Sivelestat (ONO-5046) Attenuates AngII-Induced Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice
  68. Infliximab biosimilar-induced lupus nephritis: A case report
  69. Kidney outcomes associated with haematuria and proteinuria trajectories among patients with IgA nephropathy in real‐world clinical practice: The Japan Chronic Kidney Disease Database
  70. Role of Semaphorin 3A in Kidney Development and Diseases
  71. MicroRNAs as Biomarkers and Therapeutic Targets for Acute Kidney Injury
  72. Semaphorin 3A Signaling in Kidney Development and Diseases
  73. Urinary growth differentiation factor 15 predicts renal function decline in diabetic kidney disease
  74. Co-occurrence of Three Systemic Diseases: ANCA-associated Vasculitis, Sjögren's syndrome and Sarcoidosis
  75. Editorial: Myriad types of cell death in nephropathy and their veiled potential
  76. Role of glycosylphosphatidylinositol‐anchored high‐density lipoprotein binding protein 1 in hypertriglyceridemia and diabetes
  77. Retroperitoneal Solid Pseudopapillary Tumor Mimicking Adrenal Malignant Tumor in a 67-Year-Old Man
  78. NDUFS4 Regulates Cristae Remodeling in Diabetic Kidney Disease
  79. Effects of Agalsidase Alfa Enzyme Replacement Therapy on Left Ventricular Hypertrophy on Electrocardiogram in a Female Patient with Fabry Disease
  80. The Association of Grit With Burnout Components (Professional Efficacy, Exhaustion, and Cynicism) Among Academic Rheumatologists
  81. Amelioration of nephritis in receptor for advanced glycation end-products (RAGE)-deficient lupus-prone mice through neutrophil extracellular traps
  82. Abstract 585: Sivelestat Attenuates Angii-induced Abdominal Aortic Aneurysms In Apolipoprotein E-deficient Mice
  83. The Effect of Medical Cooperation in the CKD Patients: 10-Year Multicenter Cohort Study
  84. Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy
  85. E3-ubiquitin ligases and recent progress in osteoimmunology
  86. Association of alcohol consumption and fatigue in SLE: A cross-sectional study from Lupus Registry of Nationwide Institution (LUNA) cohort
  87. Association between Urinary Creatinine Excretion and Hypothyroidism in Patients with Chronic Kidney Disease
  88. A case of sitosterolaemia-caused systemic large-vessel stenosis mimicking Takayasu arteritis in which FDG-PET provided a clue for the differential diagnosis
  89. Metformin and Its Immune-Mediated Effects in Various Diseases
  90. Effect of Low-Density Lipoprotein Apheresis on Quality of Life in Patients with Diabetes, Proteinuria, and Hypercholesterolemia
  91. Genome-wide association study of the risk of chronic kidney disease and kidney-related traits in the Japanese population: J-Kidney-Biobank
  92. Masked CKD in hyperthyroidism and reversible CKD status in hypothyroidism
  93. First-in-human autologous implantation of genetically modified adipocytes expressing LCAT for the treatment of familial LCAT deficiency
  94. Suramin prevents the development of diabetic kidney disease by inhibiting NLRP3 inflammasome activation in KK‐Ay mice
  95. Cover Image, Volume 24, Issue 12
  96. The Beneficial Effect of Personalized Lifestyle Intervention in Chronic Kidney Disease Follow-Up Project for National Health Insurance Specific Health Checkup: A Five-Year Community-Based Cohort Study
  97. Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetic Kidney Disease: A Multicenter, Open-Label, Prospective Study
  98. The association between hypothyroidism and proteinuria in patients with chronic kidney disease: a cross-sectional study
  99. Pharmacologic inhibition of PARP5, but not that of PARP1 or 2, promotes cytokine production and osteoclastogenesis through different pathways
  100. Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan
  101. Edaravone Attenuated Angiotensin II-Induced Atherosclerosis and Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice
  102. Cilostazol Attenuates AngII-Induced Cardiac Fibrosis in apoE Deficient Mice
  103. Effects of Wnt-β-Catenin Signaling and Sclerostin on the Phenotypes of Rat Pheochromocytoma PC12 Cells
  104. Real-world data on vitamin D supplementation and its impacts in systemic lupus erythematosus: Cross-sectional analysis of a lupus registry of nationwide institutions (LUNA)
  105. Simulation for ultrasound‐guided renal biopsy using boiled egg
  106. POS1475-HPR THE MINIMALLY IMPORTANT DIFFERENCE AS THE INTERPRETABILITY OF EMOTIONAL HEALTH DOMAIN IN JAPANESE VERSION OF LupusPRO FOR SLE PATIENTS; PRELIMINARY RESULTS OF A PROSPECTIVE COHORT STUDY
  107. A case of recurrent IgG4-related disease successfully treated with belimumab after remission of systemic lupus erythematosus
  108. Analysis of Inflammatory Cytokines and Estimated Glomerular Filtration Rate Decline in Japanese Patients with Diabetic Kidney Disease: A Pilot Study
  109. Potential Strategies for Kidney Regeneration With Stem Cells: An Overview
  110. Glycoprotein nonmetastatic melanoma protein B regulates lysosomal integrity and lifespan of senescent cells
  111. Obesity and Dyslipidemia Synergistically Exacerbate Psoriatic Skin Inflammation
  112. Tankyrase represses autoinflammation through the attenuation of TLR2 signaling
  113. Vasohibin-1 has α-tubulin detyrosinating activity in glomerular podocytes
  114. Circulating GPIHBP1 levels and microvascular complications in patients with type 2 diabetes: A cross-sectional study
  115. Silica-associated systemic lupus erythematosus with lupus nephritis and lupus pneumonitis
  116. Prevalence of Chronic Kidney Disease and Variation of Its Risk Factors by the Regions in Okayama Prefecture
  117. The Association of Postprandial Triglyceride Variability with Renal Dysfunction and Microalbuminuria in Patients with Type 2 Diabetic Mellitus: A Retrospective and Observational Study
  118. Adipocyte-Specific Inhibition of Mir221/222 Ameliorates Diet-Induced Obesity Through Targeting Ddit4
  119. A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
  120. Mesenchymal stem cells-derived extracellular vesicles as ‘natural’ drug delivery system for tissue regeneration
  121. Development of Urinary Diagnostic Biomarker for IgA Nephropathy by Lectin Microarray
  122. Management of corticosteroid-dependent eosinophilic interstitial nephritis
  123. Corrigendum: Upregulation of Mir342 in Diet-Induced Obesity Mouse and the Hypothalamic Appetite Control
  124. Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice
  125. Semaporin3A inhibitor ameliorates renal fibrosis through the regulation of JNK signaling
  126. Corrigendum: Upregulation of Mir342 in Diet-Induced Obesity Mouse and the Hypothalamic Appetite Control
  127. Sodium–Glucose Cotransporter 2 Inhibitors Work as a “Regulator” of Autophagic Activity in Overnutrition Diseases
  128. SGLT2 Inhibitors vs Other Glucose-Lowering Drugs: Kidney Outcomes in Real-World Clinical Practice
  129. Blood concentrations of tacrolimus upon conversion from rabeprazole to vonoprazan in renal transplant recipients: Correlation with cytochrome P450 gene polymorphisms
  130. Commentary on Intraglumerular dysfunction predicts kidney failure in the type 2 diabetes
  131. Author Correction: Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2
  132. Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor‐induced diabetes mellitus: A report of two cases
  133. Presence of decoy cells for 6 months on urine cytology efficiently predicts BK virus nephropathy in renal transplant recipients
  134. Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments
  135. Current Diagnosis and Management of Primary Chylomicronemia
  136. Upregulation of Mir342 in Diet-Induced Obesity Mouse and the Hypothalamic Appetite Control
  137. Kidney cyst infection through a fistula between bladder and retroperitoneal abscess in a polycystic kidney disease patient
  138. Total vascular resistance, augmentation index, and augmentation pressure increase in patients with peripheral artery disease
  139. Diagnosis and Management of Sitosterolemia 2021
  140. Association of blood pressure and renal outcome in patients with chronic kidney disease; a post hoc analysis of FROM-J study
  141. Corrigendum: RUNX2 Phosphorylation by Tyrosine Kinase ABL Promotes Breast Cancer Invasion
  142. Successful deceased donor kidney transplantation to a recipient with a history of COVID-19 treatment
  143. Feasible kidney donation with living marginal donors, including diabetes mellitus
  144. The effect of Humanitude care methodology on improving empathy: a six-year longitudinal study of medical students in Japan
  145. ABO Blood Incompatibility Positively Affects Early Graft Function: Single-Center Retrospective Cohort Study
  146. RUNX2 Phosphorylation by Tyrosine Kinase ABL Promotes Breast Cancer Invasion
  147. Novel Urinary Glycan Biomarkers Predict Cardiovascular Events in Patients With Type 2 Diabetes: A Multicenter Prospective Study With 5-Year Follow Up (U-CARE Study 2)
  148. Orexin A Enhances Pro-Opiomelanocortin Transcription Regulated by BMP-4 in Mouse Corticotrope AtT20 Cells
  149. Endonuclease increases efficiency of osteoblast isolation from murine calvariae
  150. Fisetin Attenuates Lipopolysaccharide-Induced Inflammatory Responses in Macrophage
  151. The resolution of immunofluorescent pathological images affects diagnosis for not only artificial intelligence but also human
  152. Acute Kidney Injury Caused by Evans Syndrome with Systemic Lupus Erythematosus and Systemic Sclerosis
  153. THE IMPACT OF BLOOD PRESSURE MANAGEMENT IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A MULTICENTER PROSPECTIVE COHORT STUDY IN JAPAN
  154. A Vaspin–HSPA1L complex protects proximal tubular cells from organelle stress in diabetic kidney disease
  155. Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2
  156. Association of glucocorticoid doses and emotional health in lupus low disease activity state (LLDAS): a cross-sectional study
  157. Novel urinary glycan profiling by lectin array serves as the biomarkers for predicting renal prognosis in patients with IgA nephropathy
  158. Deletion of Mir223 Exacerbates Lupus Nephritis by Targeting S1pr1 in Faslpr/lpr Mice
  159. Granulomatosis with polyangiitis with obstructive pneumonia progressing to hypertrophic pachymeningitis
  160. Current Status of Familial LCAT Deficiency in Japan
  161. MicroRNAs as Biomarkers for Nephrotic Syndrome
  162. Vasohibin-2 Aggravates Development of Ascending Aortic Aneurysms but not Abdominal Aortic Aneurysms nor Atherosclerosis in ApoE-Deficient Mice
  163. Risk of higher dose methotrexate for renal impairment in patients with rheumatoid arthritis
  164. Dynamin 1 is important for microtubule organization and stabilization in glomerular podocytes
  165. Low‐dose rituximab induction therapy is effective in immunological high‐risk renal transplantation without increasing cytomegalovirus infection
  166. Inhibition of interleukin-6 signaling attenuates aortitis, left ventricular hypertrophy and arthritis in interleukin-1 receptor antagonist deficient mice
  167. Multicentric Reticulohistiocytosis in a Patient with Hand Contracture
  168. Dysfunction of CD8 + PD-1 + T cells in type 2 diabetes caused by the impairment of metabolism-immune axis
  169. Tubulointerstitial Nephritis Cases With IgM-Positive Plasma Cells
  170. Effects of LDL apheresis on proteinuria in patients with diabetes mellitus, severe proteinuria, and dyslipidemia
  171. Tubulointerstitial Nephritis and Uveitis Caused by Sjögren Syndrome Without Dryness
  172. Deep Learning Could Diagnose Diabetic Nephropathy with Renal Pathological Immunofluorescent Images
  173. Takayasu phlebitis
  174. Adult kidney stem/progenitor cells contribute to regeneration through the secretion of trophic factors
  175. Genetic Deletion of Vasohibin-2 Exacerbates Ischemia-Reperfusion-Induced Acute Kidney Injury
  176. The Protective Effect of Chlorogenic Acid on Vascular Senescence via the Nrf2/HO-1 Pathway
  177. Podocytopathy as ‘stand-alone’ involvement in systemic lupus erythematosus: a case report
  178. Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury
  179. Sodium Glucose Co-Transporter 2 Inhibitor Ameliorates Autophagic Flux Impairment on Renal Proximal Tubular Cells in Obesity Mice
  180. Recovery from hypoxemia and Hypercapnia following noninvasive pressure support ventilation in a patient with statin-associated necrotizing myopathy: a case report
  181. Association of explanatory histological findings and urinary protein and serum creatinine levels at renal biopsy in lupus nephritis: a cross-sectional study
  182. AB0387 TREATMENT STATUS FOR OSTEOPOROSIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: CROSS-SECTIONAL ANALYSIS FROM A LUPUS REGISTRY OF NATIONWIDE INSTITUTIONS (LUNA)
  183. Nivolumab-induced IgA nephropathy in a patient with advanced gastric cancer
  184. Pembrolizumab-induced hypothyroidism caused reversible increased serum creatinine levels: a case report
  185. Targeting angiogenesis and lymphangiogenesis in kidney disease
  186. Conditions, pathogenesis, and progression of diabetic kidney disease and early decliner in Japan
  187. Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials
  188. Podocyte autophagy is associated with foot process effacement and proteinuria in patients with minimal change nephrotic syndrome
  189. Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Renal Diseases
  190. Damage accrual related to pregnancies before and after diagnosis of systemic lupus erythematosus: a cross-sectional and nested case-control analysis from a lupus registry
  191. A novel homoplasmic mitochondrial DNA mutation (m.13376T>C, p.I347T) of MELAS presenting characteristic medial temporal lobe atrophy
  192. Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib
  193. Simultaneous development of IgA vasculitis and eosinophilic granulomatosis with polyangiitis
  194. HIV-associated Immune Complex Kidney Disease with C3-dominant Deposition Induced by HIV Infection after Treatment of IgA Nephropathy
  195. The hypoglycemia-prevention effect of sensor-augmented pump therapy with predictive low glucose management in Japanese patients with type 1 diabetes mellitus: a short-term study
  196. Renal tubular injury exacerbated by vasohibin-1 deficiency in a murine cisplatin-induced acute kidney injury model
  197. Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis
  198. Report of health checkup system for chronic kidney disease in general population in Okayama city: effect of health guidance intervention on chronic kidney disease outcome
  199. Urine 5MedC, a Marker of DNA Methylation, in the Progression of Chronic Kidney Disease
  200. Combination of Renal Angioplasty and Angiotensin-converting-enzyme Inhibitor Can Reduce Proteinuria in Patients with Bilateral Renal Artery Disease
  201. Capnocytophaga canimorsus peritonitis diagnosed by mass spectrometry in a diabetic patient undergoing peritoneal dialysis: a case report
  202. Withdrawal: Isolation and functional analysis of mouse UbA52 gene and its relevance to diabetic nephropathy.
  203. THU0175 DOSE-DEPENDENT RISK OF METHOTREXATE FOR RENAL IMPAIRMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
  204. THU0310 OPTIMAL INITIAL DOSE OF GLUCOCORTICOID FOR ELDERLY-ONSET ANCA ASSOCIATED VASCULITIS: SAFTY OUTOCOME ANALYSIS OF TWO NATIONWIDE, PROSPECTIVE, INCEPTION COHORT STUDIES
  205. Inhibitory Effects of Tofogliflozin on Cardiac Hypertrophy in Dahl Salt-Sensitive and Salt-Resistant Rats Fed a High-Fat Diet
  206. Impaired mental health status in patients with chronic kidney disease is associated with estimated glomerular filtration rate decline
  207. Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease
  208. Parathyroid Lipoadenoma: A Pitfall in Preoperative Localization
  209. Exogenous Vasohibin-2 Exacerbates Angiotensin II-Induced Ascending Aortic Dilation in Mice
  210. MON-485 Effects of Orexin A on Prolactin Production by Regulating BMP-4 Activity in Rat Pituitary Lactotorope Cells
  211. Reply
  212. Orexin A modulates prolactin production by regulating BMP-4 activity in rat pituitary lactotorope cells
  213. Regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice derived CD4+ T cells
  214. Development of Hypertrophic Pachymeningitis in a Patient With Antineutrophil Cytoplasmic Antibody–Negative Eosinophilic Granulomatosis With Polyangiitis
  215. Hemoptysis Originating from the Bronchial Artery in Takayasu Arteritis with Ulcerative Colitis
  216. Multiple nodular pulmonary amyloidosis in a patient with rheumatoid arthritis
  217. Thrombocytosis as a prognostic factor in polymyalgia rheumatica: characteristics determined from cluster analysis
  218. GPIHBP1 autoantibody syndrome during interferon β1a treatment
  219. Secretomes from Mesenchymal Stem Cells against Acute Kidney Injury: Possible Heterogeneity
  220. Abdominal aortic aneurysm in aged population
  221. Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports
  222. Antineutrophil cytoplasmic antibody-positive familial Mediterranean fever and hyperthyroidism
  223. The clinical efficacy of angiotensin II type1 receptor blockers on inflammatory markers in patients with hypertension: a multicenter randomized-controlled trial; MUSCAT-3 study
  224. The relationship between repeated measurement of casual and 24-h urinary sodium-to-potassium ratio in patients with chronic kidney disease
  225. Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus
  226. Diabetic nephropathy is associated with frailty in patients with chronic hemodialysis
  227. An open-label pilot study on preventing glucocorticoid-induced diabetes mellitus with linagliptin
  228. Lymphoproliferative disease in a patient with Takayasu arteritis and ulcerative colitis
  229. Correction: Downregulation of miR-200a-3p, Targeting CtBP2 Complex, Is Involved in the Hypoproduction of IL-2 in Systemic Lupus Erythematosus–Derived T Cells
  230. Renal expression of trefoil factor 3 mRNA in association with tubulointerstitial fibrosis in IgA nephropathy
  231. Reply
  232. Chronic kidney disease is associated with carotid atherosclerosis and symptomatic ischaemic stroke
  233. Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression
  234. Cluster Analysis Using Anti–Aminoacyl-tRNA Synthetases and SS-A/Ro52 antibodies in Patients With Polymyositis/Dermatomyositis
  235. Identification of Novel Urinary Biomarkers for Predicting Renal Prognosis in Patients With Type 2 Diabetes by Glycan Profiling in a Multicenter Prospective Cohort Study: U-CARE Study 1
  236. AB1322 Treatment response as a predictor for refractory disease and/or transition to rheumatoid arthritis in patients with polymyalgia rheumatica
  237. Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model
  238. Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model
  239. Cilostazol Attenuates Angiotensin II–Induced Abdominal Aortic Aneurysms but Not Atherosclerosis in Apolipoprotein E–Deficient Mice
  240. Estrogen-related receptor α is essential for maintaining mitochondrial integrity in cisplatin-induced acute kidney injury
  241. Incretins modulate progesterone biosynthesis by regulating bone morphogenetic protein activity in rat granulosa cells
  242. Serum cystatin C is an independent biomarker associated with the renal resistive index in patients with chronic kidney disease
  243. Refractory neuromyelitis optica spectrum disorder in systemic lupus erythematosus successfully treated with rituximab
  244. Cavernous Transformation and Granulomatous Epididymis in Behçet Disease
  245. Peripheral artery disease is associated with frailty in chronic hemodialysis patients
  246. The KCNQ1 gene polymorphism as a shared genetic risk for rheumatoid arthritis and chronic periodontitis in japanese adults: A pilot case-control study
  247. Development of a novel estimation method for hemoglobin A1c using glycated albumin in type 2 diabetes mellitus patients with end-stage renal disease
  248. Effect of an enhanced recovery after surgery protocol in patients undergoing pancreaticoduodenectomy: A randomized controlled trial
  249. Urine Trefoil Factors as Prognostic Biomarkers in Chronic Kidney Disease
  250. The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients
  251. High calcium enhances the expression of double-stranded RNA sensors and antiviral activity in epidermal keratinocytes
  252. The effects of non-surgical periodontal treatment on glycemic control, oxidative stress balance and quality of life in patients with type 2 diabetes: A randomized clinical trial
  253. Rationale and study design of a clinical trial to assess the effects of LDL apheresis on proteinuria in diabetic patients with severe proteinuria and dyslipidemia
  254. Primary peritoneal carcinosarcoma in a dialysis patient
  255. Impact of nocturnal blood pressure variability on renal arterioles
  256. Cardiovocal syndrome (Ortner syndrome) associated with secondary pulmonary arterial hypertension in a patient with mixed connective tissue disease
  257. Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice
  258. Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
  259. Regulatory role of melatonin and BMP-4 in prolactin production by rat pituitary lactotrope GH3 cells
  260. The level of urinary semaphorin3A is associated with disease activity in patients with minimal change nephrotic syndrome
  261. Downregulation of miR-200a-3p, Targeting CtBP2 Complex, Is Involved in the Hypoproduction of IL-2 in Systemic Lupus Erythematosus–Derived T Cells
  262. A retrospective observational study of glucocorticoid-induced diabetes mellitus with IgA nephropathy treated with tonsillectomy plus methylprednisolone pulse therapy
  263. Anti-SS-A/Ro antibody positivity as a risk factor for relapse in patients with polymyositis/dermatomyositis
  264. Reprogramming of metabolism in immune-mediated cells
  265. Nodular lesions in diabetic nephropathy: Collagen staining and renal prognosis
  266. Practical efficacy of olmesartan versus azilsartan in patients with hypertension
  267. Antiangiogenic Therapy for Diabetic Nephropathy
  268. Arterial Stiffness is an Independent Risk Factor for Anemia After Percutaneous Native Kidney Biopsy
  269. Azathioprine Intolerance in Japanese Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
  270. Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-associated Vasculitis
  271. Melatonin regulates catecholamine biosynthesis by modulating bone morphogenetic protein and glucocorticoid actions
  272. Occurrence of Dermatomyositis Immediately after Mastectomy Subsequent to Severe Chemotherapeutic Drug Eruption
  273. Sustained Tubulointerstitial Inflammation in Kidney with Severe Leptospirosis
  274. The Successful Treatment of Refractory Polyarteritis Nodosa Using Infliximab
  275. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents
  276. Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver disease
  277. Chronic Kidney Disease Is Positively and Diabetes Mellitus Is Negatively Associated with Abdominal Aortic Aneurysm
  278. ANGPTL2 activity in cardiac pathologies accelerates heart failure by perturbing cardiac function and energy metabolism
  279. The possible involvement of intestine-derived IgA1: a case of IgA nephropathy associated with Crohn’s disease
  280. Salt and sugar: Bad company
  281. Inhibition of SGLT2 alleviates diabetic nephropathy by suppressing high glucose‐induced oxidative stress in type 1 diabetic mice
  282. Acute idiopathic blue fingers: a young man with Achenbach's syndrome
  283. Development of intracerebral hemorrhage in the short-term clinical course of a patient with microscopic polyangiitis without neurological symptoms at diagnosis: an autopsy case
  284. Antiobesity Action of ACAM by Modulating the Dynamics of Cell Adhesion and Actin Polymerization in Adipocytes
  285. Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis
  286. <i>CDH13</i> Polymorphisms are Associated with Adiponectin Levels and Metabolic Syndrome Traits Independently of Visceral Fat Mass
  287. Bilateral Abducens Nerve Palsy due to Idiopathic Intracranial Hypertension as an Initial Manifestation of Systemic Lupus Erythematosus
  288. Risk Factors for the Requirement of Antenatal Insulin Treatment in Gestational Diabetes Mellitus
  289. Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis
  290. Innate immunity in diabetes and diabetic nephropathy
  291. The efficacy of add-on tacrolimus for minor flare in patients with systemic lupus erythematosus: a retrospective study
  292. Translocase of inner mitochondrial membrane 44 alters the mitochondrial fusion and fission dynamics and protects from type 2 diabetes
  293. Risk factors for the development of glucocorticoid-induced diabetes mellitus
  294. Identification of Circulating miR-101, miR-375 and miR-802 as Biomarkers for Type 2 Diabetes
  295. Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial
  296. Autoimmune pancreatitis and minimal change nephrotic syndrome: an unusual association?
  297. <i>ADIPOQ</i> polymorphisms are associated with insulin resistance in Japanese women
  298. Structural design and synthesis of arylalkynyl amide-type peroxisome proliferator-activated receptor γ (PPARγ)-selective antagonists based on the helix12-folding inhibition hypothesis
  299. Cognitive and affective functions in diabetic patients associated with diabetes-related factors, white matter abnormality and aging
  300. Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice
  301. Pemt Deficiency Ameliorates Endoplasmic Reticulum Stress in Diabetic Nephropathy
  302. Nuclear Hormone Receptor Expression in Mouse Kidney and Renal Cell Lines
  303. Sarcoid-like lung granulomas in a hemodialysis patient treated with a dipeptidyl peptidase-4 inhibitor
  304. Serum vaspin levels are associated with physical activity or physical fitness in Japanese: a pilot study
  305. Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats
  306. Metallothionein deficiency exacerbates diabetic nephropathy in streptozotocin-induced diabetic mice
  307. The Chemiexcitation of the Chemiluminescence of Lophine Peroxide Anions via a Partially Cyclic Transition State
  308. Long-term effect of cinacalcet hydrochloride on abdominal aortic calcification in patients on hemodialysis with secondary hyperparathyroidism
  309. Erratum
  310. Urinary Fetuin-A Is a Novel Marker for Diabetic Nephropathy in Type 2 Diabetes Identified by Lectin Microarray
  311. Urinary angiotensinogen is a marker for tubular injuries in patients with type 2 diabetes
  312. Visceral Adipose Tissue-derived Serine Proteinase Inhibitor Inhibits Apoptosis of Endothelial Cells as a Ligand for the Cell-Surface GRP78/Voltage-dependent Anion Channel Complex
  313. Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease
  314. Telmisartan Attenuates Diabetic Nephropathy by Suppressing Oxidative Stress in <b><i>db/db</i></b> Mice
  315. <i>NUDT3</i> rs206936 is associated with body mass index in obese Japanese women
  316. Erratum
  317. Replication Study of 15 Recently Published Loci for Body Fat Distribution in the Japanese Population
  318. The serum vaspin levels are reduced in Japanese chronic hemodialysis patients
  319. Activation of Liver X Receptor Inhibits Osteopontin and Ameliorates Diabetic Nephropathy
  320. Vaspin Is an Adipokine Ameliorating ER Stress in Obesity as a Ligand for Cell-Surface GRP78/MTJ-1 Complex
  321. Inflammation and the pathogenesis of diabetic nephropathy
  322. Case of emphysematous cholecystitis in a patient with type 2 diabetes mellitus associated with schizophrenia
  323. Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice
  324. Current status of the treatment of microscopic polyangiitis and granulomatosis with polyangiitis in Japan
  325. Serum Vaspin Concentrations Are Closely Related to Insulin Resistance, and rs77060950 atSERPINA12Genetically Defines Distinct Group with Higher Serum Levels in Japanese Population
  326. The therapeutic potential of synthetic human atrial natriuretic peptide in nephrotic syndrome: a randomized controlled trial
  327. The effects of telmisartan treatment on the abdominal fat depot in patients with metabolic syndrome and essential hypertension: Abdominal fat Depot Intervention Program of Okayama (ADIPO)
  328. Association between type 2 diabetes genetic susceptibility loci and visceral and subcutaneous fat area as determined by computed tomography
  329. RXR antagonism induces G0/G1 cell cycle arrest and ameliorates obesity by up‐regulating the p53–p21$^{\rm{Cip1}}$ pathway in adipocytes
  330. Galectin-9 and T Cell Immunoglobulin Mucin-3 Pathway Is a Therapeutic Target for Type 1 Diabetes
  331. A Case of Type 2 Diabetes and Metastatic Liver Cancer Exhibiting Hypercholesterolemia with Abnormal Lipoproteins
  332. Impact of circulating vaspin levels on metabolic variables in elderly twins
  333. Genetic variations in the CYP17A1 and NT5C2 genes are associated with a reduction in visceral and subcutaneous fat areas in Japanese women
  334. Association of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese population
  335. Computed tomography analysis of the association between the SH2B1 rs7498665 single-nucleotide polymorphism and visceral fat area
  336. Two novel mutations of lecithin:cholesterol acyltransferase (LCAT) gene and the influence of APOE genotypes on clinical manifestations
  337. Icodextrin Increases Technique Survival Rate in Peritoneal Dialysis Patients with Diabetic Nephropathy by Improving Body Fluid Management: A Randomized Controlled Trial
  338. Activation of Peroxisome Proliferator–Activated Receptor δ Inhibits Streptozotocin-Induced Diabetic Nephropathy Through Anti-Inflammatory Mechanisms in Mice
  339. Discovery of Genes Related to Diabetic Nephropathy in Various Animal Models by Current Techniques
  340. High Glucose Increases Metallothionein Expression in Renal Proximal Tubular Epithelial Cells
  341. 3. Obesity and New Secretory Factors. 1) Vaspin.
  342. Intercellular adhesion molecule-1 plays a critical role in glomerulosclerosis after subtotal nephrectomy
  343. Insufficient control of morning home blood pressure in Japanese patients with hypertension associated with diabetes mellitus
  344. Peramivir for Severe Influenza Infection in a Patient with Diabetic Nephropathy
  345. P-Selectin Glycoprotein Ligand-1 Deficiency Is Protective Against Obesity-Related Insulin Resistance
  346. Polymorphisms in NRXN3, TFAP2B, MSRA, LYPLAL1, FTO and MC4R and their effect on visceral fat area in the Japanese population
  347. In Vivo Delivery of Gremlin siRNA Plasmid Reveals Therapeutic Potential against Diabetic Nephropathy by Recovering Bone Morphogenetic Protein-7
  348. Comparison of Insulin Detemir and Insulin Glargine on Glycemic Variability in Patients with Type 1 and Type 2 Diabetes
  349. The Usefulness of Super-Selective Computed Tomography Angiography (CTA) for Diagnosing and Localizing a Small Insulinoma
  350. Association between obesity and polymorphisms in SEC16B, TMEM18, GNPDA2, BDNF, FAIM2 and MC4R in a Japanese population
  351. Endothelial barrier protection by FTY720 under hyperglycemic condition: involvement of focal adhesion kinase, small GTPases, and adherens junction proteins
  352. Historical chronology of basic and clinical research in diabetic nephropathy and contributions of Japanese scientists
  353. Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy
  354. Enhanced interaction between focal adhesion and adherens junction proteins: Involvement in sphingosine 1-phosphate-induced endothelial barrier enhancement
  355. Screening of 336 single-nucleotide polymorphisms in 85 obesity-related genes revealed McKusick–Kaufman syndrome gene variants are associated with metabolic syndrome
  356. Rap1b GTPase Ameliorates Glucose-Induced Mitochondrial Dysfunction
  357. Bilateral dystonia in type 1 diabetes: a case report
  358. Collectrin Is Involved in the Development of Salt-Sensitive Hypertension by Facilitating the Membrane Trafficking of Apical Membrane Proteins via Interaction With Soluble N -Ethylmaleiamide-Sensitive Factor Attachment Pro...
  359. INSIG2 gene rs7566605 polymorphism is associated with severe obesity in Japanese
  360. Comparison of serum uric acid levels between Japanese with and without metabolic syndrome
  361. Procollagen C-proteinase enhancer-1 (PCPE-1) interacts with β2-microglobulin (β2-m) and may help initiate β2-m amyloid fibril formation in connective tissues
  362. Variations in the FTO gene are associated with severe obesity in the Japanese
  363. Vaspin: a novel serpin with insulin-sensitizing effects
  364. Diabetic Nephropathy: Mechanisms of Renal Disease Progression
  365. Collectrin, a homologue of ACE2, its transcriptional control and functional perspectives
  366. Edaravone mimics sphingosine-1-phosphate-induced endothelial barrier enhancement in human microvascular endothelial cells
  367. Glycated albumin levels predict long‐term survival in diabetic patients undergoing haemodialysis
  368. Association of single-nucleotide polymorphisms in MTMR9 gene with obesity
  369. Comparison of ventilatory threshold and exercise habits between Japanese men with and without metabolic syndrome
  370. Urinary PGDS levels are associated with vascular injury in type 2 diabetes patients
  371. The Role for HNF-1β-Targeted Collectrin in Maintenance of Primary Cilia and Cell Polarity in Collecting Duct Cells
  372. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-κB activation
  373. Functional Single-Nucleotide Polymorphisms in the Secretogranin III (SCG3) Gene that Form Secretory Granules with Appetite-Related Neuropeptides Are Associated with Obesity
  374. Changes of gene expression profiles in macrophages stimulated by angiotensin II — Angiotensin II induces MCP-2 through AT1-receptor
  375. Errata
  376. Macrophage Scavenger Receptor-A–Deficient Mice Are Resistant Against Diabetic Nephropathy Through Amelioration of Microinflammation
  377. Hemophagocytic Syndrome Associated with Fatal Veno-Occlusive Disease in the Liver
  378. Severe Hypoglycemia Induced by IGF-II Producing Non-Islet Cell Tumor
  379. Thiazolidinediones Ameliorate Diabetic Nephropathy via Cell Cycle–Dependent Mechanisms
  380. Elevated Serum Monocyte Chemoattractant Protein‐4 and Chronic Inflammation in Overweight Subjects
  381. Therapeutic Approach for Diabetic Nephropathy Using Gene Delivery of Translocase of Inner Mitochondrial Membrane 44 by Reducing Mitochondrial Superoxide Production
  382. Relationship between Metabolic Syndrome and Cigarette Smoking in the Japanese Population
  383. Relationship between Metabolic Syndrome and Proteinuria in the Japanese Population
  384. The Application of Synthetic hANP in Diabetic Nephropathy With Nephrotic Syndrome
  385. Modulation of renal-specific oxidoreductase/ myo -inositol oxygenase by high-glucose ambience
  386. Serum Interleukin-18 Levels Are Associated With Nephropathy and Atherosclerosis in Japanese Patients With Type 2 Diabetes
  387. The HNF-1 target Collectrin controls insulin exocytosis by SNARE complex formation
  388. Galectin-9 Inhibits Glomerular Hypertrophy in db/db Diabetic Mice via Cell-Cycle–Dependent Mechanisms
  389. Methotrexate Prevents Renal Injury in Experimental Diabetic Rats via Anti-Inflammatory Actions
  390. Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats
  391. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients
  392. Gene Delivery of Tim44 Reduces Mitochondrial Superoxide Production and Ameliorates Neointimal Proliferation of Injured Carotid Artery in Diabetic Rats
  393. Renal-specific oxidoreductase biphasic expression under high glucose ambience during fetal versus neonatal development
  394. Clinical features of non-diabetic renal diseases in patients with type 2 diabetes
  395. Cell Biology of Diabetic Kidney Disease
  396. Visceral adipose tissue-derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity
  397. Pathological Roles of Advanced Glycation End Product Receptors SR‐A and CD36
  398. Hyperglycemia: its imminent effects on mammalian nephrogenesis
  399. Identification of adipocyte adhesion molecule (ACAM), a novel CTX gene family, implicated in adipocyte maturation and development of obesity
  400. Sulfated Hyaluronic Acid, a Potential Selectin Inhibitor, Ameliorates Experimentally Induced Crescentic Glomerulonephritis
  401. The Critical Role of Src Homology Domain 2–Containing Tyrosine Phosphatase-1 in Recombinant Human Erythropoietin Hyporesponsive Anemia in Chronic Hemodialysis Patients
  402. Intravenous Vitamin D Therapy Reduces PTH-(1–84)/Large C Fragments Ratio in Chronic Hemodialysis Patients
  403. Changes in serum leptin concentrations in overweight Japanese men after exercise
  404. The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats
  405. Update of extracellular matrix, its receptors, and cell adhesion molecules in mammalian nephrogenesis
  406. Cerebroside Sulfotransferase Deficiency Ameliorates L-selectin-dependent Monocyte Infiltration in the Kidney after Ureteral Obstruction
  407. Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?
  408. Daily exercise lowers blood pressure and reduces visceral adipose tissue areas in overweight Japanese men
  409. Pathogenesis of IgA nephropathy
  410. Serum bFGF levels are reduced in Japanese overweight men and restored by a 6-month exercise education
  411. Intercellular Adhesion Molecule-1–Deficient Mice Are Resistant Against Renal Injury After Induction of Diabetes
  412. Gene Regulation of Aldose-, Aldehyde- and a Renal Specific Oxido Reductase (RSOR) in the Pathobiology of Diabetes Mellitus
  413. Pelvic lymphocyst infection associated with maternally inherited diabetes mellitus
  414. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats
  415. Glomerular cell apoptosis in human lupus nephritis
  416. Successful treatment of necrotizing fasciitis associated with diabetic nephropathy
  417. Imprinted mesodermal specific transcript (MEST) and H19 genes in renal development and diabetes
  418. Perturbation of autocrine/paracrine loops of burst-forming units of erythroid-derived cells in rHuEPO-hyporesponsive hemodialysis patients
  419. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats
  420. Remission and Regression of Diabetic Nephropathy
  421. Protective effect of a novel and selective inhibitor of inducible nitric oxide synthase on experimental crescentic glomerulonephritis in WKY rats
  422. Daily walking reduces visceral adipose tissue areas and improves insulin resistance in Japanese obese subjects
  423. A case of congenital generalized lipodystrophy with lipoatrophic diabetes developing anti‐insulin antibodies
  424. Beraprost sodium, prostacyclin analogue, attenuates glomerular hyperfiltration and glomerular macrophage infiltration by modulating ecNOS expression in diabetic rats
  425. Relevance of extracellular matrix and its receptors in mammalian nephrogenesis revealed by metanephric organ culture system
  426. Isolation and Functional Analysis of Mouse UbA52 Gene and Its Relevance to Diabetic Nephropathy
  427. Therapeutic effect of sulphated hyaluronic acid, a potential selectin‐blocking agent, on experimental progressive mesangial proliferative glomerulonephritis
  428. Preventive effect of sulphated colominic acid on P-selectin-dependent infiltration of macrophages in experimentally induced crescentic glomerulonephritis
  429. Identification of developmentally regulated mesodermal-specific transcript in mouse embryonic metanephros
  430. Renal Gene Expression in Embryonic and Newborn Diabetic Mice
  431. Relevance of renal-specific oxidoreductase in tubulogenesis during mammalian nephron development
  432. Angiocentric immunoproliferative lesions of the lung associated with diffuse renal involvement
  433. Relationship between reduced serum IGF-I levels and accumulation of visceral fat in Japanese men
  434. Cyanotic congenital heart disease associated with glomerulomegaly and focal segmental glomerulosclerosis: remission of nephrotic syndrome with angiotensin converting enzyme inhibitor
  435. Gene expression and identification of gene therapy targets in diabetic nephropathy
  436. 内科  100年のあゆみ  腎臓 III  主要疾患の歴史 8  こう原病・血管炎
  437. Minimal Change Nephrotic Syndrome Developing during Postoperative Interferon-Beta Therapy for Malignant Melanoma
  438. Identification of up-regulated Ras-like GTPase, Rap1b, by suppression subtractive hybridization
  439. Nitric oxide system is involved in glomerular hyperfiltration in Japanese normo- and micro-albuminuric patients with type 2 diabetes
  440. Collectrin, a Collecting Duct-specific Transmembrane Glycoprotein, Is a Novel Homolog of ACE2 and Is Developmentally Regulated in Embryonic Kidneys
  441. Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis
  442. 糖尿病性腎症の診断と治療
  443. RELEVANCE OF ALDO-KETO REDUCTASE FAMILY MEMBERS TO THE PATHOBIOLOGY OF DIABETIC NEPHROPATHY AND RENAL DEVELOPMENT
  444. STATUS OF GLUCOSE TRANSPORTERS IN THE MAMMALIAN KIDNEY AND RENAL DEVELOPMENT
  445. The Necessity of Renal Biopsies in the Management of Diabetic Nephropathy
  446. Ultrastructure of Glomerular Basement Membrane in Active Heymann Nephritis Rats Revealed by Tissue-Negative Staining Method
  447. Successful use of cyclosporin A for the treatment of acute interstitial pneumonitis associated with rheumatoid arthritis
  448. Efficacy of galectins in the amelioration of nephrotoxic serum nephritis in Wistar Kyoto rats
  449. Efficacy of galectins in the amelioration of nephrotoxic serum nephritis in Wistar Kyoto rats
  450. Expression characteristics and relevance of sodium glucose cotransporter-1 in mammalian renal tubulogenesis
  451. Familial interstitial nephritis with progressive renal failure
  452. Re-evaluation of exercise prescription for Japanese type 2 diabetic patients by ventilatory threshold
  453. Identification of a renal-specific oxido-reductase in newborn diabetic mice
  454. Clinical evaluation of muscle strength in 20–79-years-old obese Japanese
  455. Malignant Hypertension with a Rare Complication of Pulmonary Alveolar Hemorrhage
  456. Role of membrane-type matrix metalloproteinase 1 (MT-1-MMP), MMP-2, and its inhibitor in nephrogenesis
  457. Novel approaches to unravel the genesis of glomerulosclerosis by new methodologies in molecular biology and molecular genetics
  458. Tubulointerstitial nephritis antigen: An extracellular matrix protein that selectively regulates tubulogenesis vs. glomerulogenesis during mammalian renal development
  459. Cloning of Rat Fibrillin-2 cDNA and Its Role in Branching Morphogenesis of Embryonic Lung
  460. Integrins Mediate the Inhibitory Effect of Focal Adhesion on Angiotensin II-Induced p44/42 Mitogen-Activated Protein (MAP) Kinase Activity in Human Mesangial Cells
  461. Screening for genes up-regulated in 5/6 nephrectomized mouse kidney
  462. Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-α and inducible nitric oxide synthase in diabetic rat glomeruli
  463. Signaling Transduction Pathway of Angiotensin II in Human Mesangial Cells: Mediation of Focal Adhesion and GTPase Activating Proteins
  464. Differential Distribution of Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Proteins in Experimental Diabetic Rat Kidney
  465. Increased Urinary Excretion of Macrophage-Colony-Stimulating Factor (M-CSF) in Patients with IgA Nephropathy: Tonsil Stimulation Enhances Urinary M-CSF Excretion
  466. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy
  467. Isolation of rat fibrillin-1 cDNA and its relevance in metanephric development
  468. Relevance of extracellular matrix, its receptors, and cell adhesion molecules in mammalian nephrogenesis
  469. Cloning of murine membrane-type-1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitor
  470. Ultrastructure of mesangial type III collagen deposition in a patient with IgA nephropathy
  471. Therapeutic effects of prostacyclin analog on crescentic glomerulonephritis of rat
  472. Characterization of mammalian translocase of inner mitochondrial membrane (Tim44) isolated from diabetic newborn mouse kidney
  473. A Case of Membranous Nephropathy Associated with Psoriasis vulgaris
  474. Deposition of Mannan Binding Protein and Mannan Binding Protein-Mediated Complement Activation in the Glomeruli of Patients with IgA Nephropathy
  475. Fatal Hyperammonemia in a Patient with Systemic Lupus Erythematosus.
  476. Developmental regulation and partial-length cloning of tubulointerstitial nephritis antigen of murine metanephros
  477. Role of extracellular matrix, growth factors and proto-oncogenes in metanephric development
  478. Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin.
  479. Representational difference analysis of cDNA of genes expressed in embryonic kidney
  480. Identification and Characterization of Galectin-9, a Novel β-Galactoside-binding Mammalian Lectin
  481. D-glucose-induced dysmorphogenesis of embryonic kidney.
  482. Comparative Role of Phosphotyrosine Kinase Domains ofc-rosandc-retProtooncogenes in Metanephric Development with Respect to Growth Factors and Matrix Morphogens
  483. Cloning of mouse integrin alphaV cDNA and role of the alphaV-related matrix receptors in metanephric development.
  484. The Critical Role of Intercellular Adhesion Molecule-1 in Masugi Nephritis in Rats
  485. Cloning of mouse c-ros renal cDNA, its role in development and relationship to extracellular matrix glycoproteins
  486. Distribution of extracellular matrix receptors in various forms of glomerulonephritis
  487. Activation of complement during hemodialysis.
  488. Immunoreactivity of the JK-132 monoclonal antibody directed against basement membrane collagen in normal and diabetic glomeruli
  489. Localization of Fibril/Microfibril and Basement Membrane Collagens in Diabetic Glomerulosclerosis in Type 2 Diabetes
  490. Distribution and relevance of insulin-like growth factor-I receptor in metanephric development
  491. Cloning of cDNA for the alpha subunit of mouse insulin-like growth factor I receptor and the role of the receptor in metanephric development.
  492. A case of neutro-Behcet's disease started with diplopia.